SEP 21, 2017 02:43 PM PDT

Leveraging Probiotics to Fight Colorectal Cancer

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

The gut microbiome is increasingly recognized as a vital player in the development of colon cancer. But good bacteria, scientists say, can help us turn the tide against the insidious disease.

The microbiome is a specialized collection of bacteria residing in specialized niches of the body. Mostly famous for their existence in the human gut, these communities of microorganisms have been known to influence processes like digestion and immune responses. The gut microbiota, in particular, has been linked to inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. In turn, these diseases increase the risk for colon cancer.

Colon cancer, also known as colon cancer or bowel cancer, is the third most common non-skin cancer type in the world. The cancer usually begins as small, benign lumps of cells that form polyps in the colon. Without proper removal, these polyps can turn cancerous and cause symptoms such as abdominal pain, rectal bleeding, weakness, and fatigue. According to a recent report, the incidence of colorectal cancer is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030.

Could good bacteria, AKA probiotics, lower the risk for colon cancer?

In the current study, scientists at the Baylor College of Medicine in Houston, Texas, focused on the effects of Lactobacillus reuteri, which is a probiotic naturally found in the guts of mammals.

The team injected L. reuteri into mice that were deficient in an enzyme called histidine decarboxylase (HDC). Without HDC, these mice are much more susceptible to develop colorectal cancer. By contrast, one of the roles of L. reuteri involves producing the enzyme HDC.

In mice treated with the probiotic, the team found less tumors, and the ones they did find were smaller in size. By contrast, animals that received the placebo treatment had more numerous and larger tumors. The results suggest the probiotic L. reuteri has protective effects against colorectal tumor formation.

"Our results suggest a significant role for histamine in the suppression of chronic intestinal inflammation and colorectal tumorigenesis [tumor formation]," says Dr. James Versalovic, a professor of pathology and immunology at Baylor, and the study’s lead author. "We have also shown that cells, both microbial and mammalian, can share metabolites or chemical compounds that together promote human health and prevent disease."

“We are on the cusp of harnessing advances in microbiome science to facilitate diagnosis and treatment of human disease. By simply introducing microbes that provide missing life substances, we can reduce the risk of cancer and supplement diet-based cancer prevention strategies,” he added.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 15, 2018
Cancer
SEP 15, 2018
Undescended testicles could lead to testicular cancer and infertility in adult males
An undescended testis (cryptorchidism) is a condition in which one of the testes or both have not descended into the right position in the scrotum at birth and either stay at the abdomen or d...
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
DEC 11, 2018
Cancer
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
DEC 09, 2018
Health & Medicine
DEC 09, 2018
Health Beliefs That Influence Skin Cancer
  In the U.S., there are over 3.5 million cases of skin cancer reported every year. Basal cell carcinoma and squamous cell carcinoma are the most comm...
JAN 24, 2019
Drug Discovery
JAN 24, 2019
Why Do Promising Cancer Drugs Fail?
After almost 20 years of a once-promising cancer drugs known as MMP inhibitors suddenly failed in clinical trials, scientists are now eager to provide an e...
JAN 31, 2019
Cell & Molecular Biology
JAN 31, 2019
Breakthrough Imaging Tool Shows How Pancreatic Cancer Forms
Scientists have learned that pancreatic cancer can form in two different ways, solving long-standing questions....
Loading Comments...